Maybe my estimates are backwards? I just thought t

Maybe my estimates are backwards? I just thought that BP would be able to launch a new product more successfully than Syneos Health if we go alone....regardless of the higher price. A lot of variables come into play. Regardless I think our revenue will be at least $500M for either scenario, with more upside both in 2020 and future years if going alone. I still prefer them to license combo and possibly even mono at the right price and keep everything else.

Please do your own due diligence. All my posts and comments are not to be considered investment advice.